1. Antioxidant activity against H2O2-induced cytotoxicity of the ethanol extract and compounds from Pyrola decorate leaves
    Xiliang Yang et al, 2017, Pharmaceutical Biology CrossRef
  2. Rehmanniae Radix in osteoporosis: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics and pharmacology
    Chenyue Liu et al, 2017, Journal of Ethnopharmacology CrossRef
  3. Iridoids and Other Monoterpenes in the Alzheimer’s Brain: Recent Development and Future Prospects
    Solomon Habtemariam, 2018, Molecules CrossRef
  4. Catalpol Inhibits Amyloid-β Generation Through Promoting α-Cleavage of APP in Swedish Mutant APP Overexpressed N2a Cells
    Zhuo Wang et al, 2018, Front. Aging Neurosci. CrossRef
  5. Traditional Oriental Medicines and Alzheimer’s Disease
    Gak Jeon Seong et al, 2018, Aging and disease CrossRef
  6. Targeting Ubiquitin Proteasome Pathway with Traditional Chinese Medicine for Treatment of Spinocerebellar Ataxia Type 3
    I-Cheng Chen et al, 2019, Am. J. Chin. Med. CrossRef
  7. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review
    Biswanath Dinda et al, 2019, European Journal of Medicinal Chemistry CrossRef
  8. Catalpol ameliorates advanced glycation end product-induced dysfunction of glomerular endothelial cells via regulating nitric oxide synthesis by inducible nitric oxide synthase and endothelial nitric oxide synthase
    Weixiang Sun et al, 2019, IUBMB Life CrossRef
  9. Catalpol in Diabetes and its Complications: A Review of Pharmacology, Pharmacokinetics, and Safety
    Ying Bai et al, 2019, Molecules CrossRef
  10. Inhibition of lncRNA Neat1 by catalpol via suppressing transcriptional activity of NF-κB attenuates cardiomyocyte apoptosis
    Guoliang Zou et al, 2019, Cell Cycle CrossRef
  11. Human-Induced Pluripotent Stem Cells and Herbal Small-Molecule Drugs for Treatment of Alzheimer’s Disease
    Wei Wuli et al, 2020, IJMS CrossRef
  12. Design, microwave synthesis, and molecular docking studies of catalpol crotonates as potential neuroprotective agent of diabetic encephalopathy
    Shuanglin Liu et al, 2020, Sci Rep CrossRef
  13. null
    Yong Wang et al, 2021 CrossRef
  14. Nanocarriers in the Enhancement of Therapeutic Efficacy of Natural Drugs
    Xiuling Li et al, 2021, BIO Integration CrossRef
  15. Therapeutic potential of catalpol and geniposide in Alzheimer’s and Parkinson’s diseases: A snapshot of their underlying mechanisms
    Xumin Zhang et al, 2021, Brain Research Bulletin CrossRef
  16. Protective Effects of Catalpol on Limb Motor Function and Ultrastructure of Hippocampal Neurons in Rats with Cerebral Ischemia
    Shanshan Xie et al, 2021, Mol Biotechnol CrossRef
  17. Loganin substantially ameliorates molecular deficits, pathologies and cognitive impairment in a mouse model of Alzheimer’s disease
    Lulin Nie et al, 2021, Aging CrossRef
  18. Feasibility of Catalpol Intranasal Administration and Its Protective Effect on Acute Cerebral Ischemia in Rats via Anti-Oxidative and Anti-Apoptotic Mechanisms
    Jinghui Wang et al, 2022, DDDT CrossRef
  19. Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
    Ilaria Piccialli et al, 2022, Front. Pharmacol. CrossRef
  20. Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer’s Disease Complicated With Osteoporosis
    Weifan Xu et al, 2022, Front. Pharmacol. CrossRef
  21. Effects of Catalpol on Alzheimer’s Disease and Its Mechanisms
    Huize Chen et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  22. Catalpol Ameliorates Oxidative Stress and Neuroinflammation after Traumatic Brain Injury in Rats
    Haibo Ni et al, 2022, Neurochem Res CrossRef
  23. null
    Yong Wang et al, 2022 CrossRef
  24. Interdisciplinary Approaches to Deal with Alzheimer’s Disease—From Bench to Bedside: What Feasible Options Do Already Exist Today?
    Irene Ablinger et al, 2022, Biomedicines CrossRef
  25. Radix Rehmanniae Praeparata (Shu Dihuang) exerts neuroprotective effects on ICV-STZ-induced Alzheimer’s disease mice through modulation of INSR/IRS-1/AKT/GSK-3β signaling pathway and intestinal microbiota
    Yunfang Su et al, 2023, Front. Pharmacol. CrossRef
  26. Unveiling the impact of Aging on BBB and Alzheimer's disease: Factors and Therapeutic implications
    Niraj Kumar Jha et al, 2024, Ageing Research Reviews CrossRef